Reaction

Diabetic Ketosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 355 reports · 7 co-occurring drugs

As of the last recalculation, Diabetic Ketosis appears in 355 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is DAPAGLIFLOZIN (PRR 159.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dapagliflozin69159.4159.7
Insulin Glargine-Yfgn1439.039.1
Empagliflozin3634.834.8
Instalax Polyethylene Glycol 3350733.733.7
Polyethylene Glycol 400733.033.0
Canagliflozin1632.832.8
Dulaglutide1510.310.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.